Stay updated on Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision tag on the page was updated to Revision: v3.6.3, replacing the previous v3.6.0. This marks a new version of the page content without substantive changes to the trial details.
    Difference
    0.0%
    Check dated 2026-06-30T02:20:45.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Recruitment status was updated to 'No longer looking for participants', indicating enrollment is closed. The page also adds new help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and updates the revision to v3.6.0, along with changing the label from 'Intervention / Treatment' to 'Intervention/Treatment'.
    Difference
    0.2%
    Check dated 2026-06-15T20:59:54.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page revision label has been updated from v3.5.4 to v3.5.5. This appears to be a minor version update for the page documentation and related text.
    Difference
    0.0%
    Check dated 2026-06-08T17:42:08.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Updated the page's revision history to include Revision: v3.5.4 and remove Revision: v3.5.3, reflecting the latest document version.
    Difference
    0.0%
    Check dated 2026-05-18T05:57:19.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The Taoyuan District listing was replaced with Taoyuan, reflecting a city-level designation with the same postal code 33305. This aligns the location with the actual site and improves accuracy for recruitment and contact information.
    Difference
    0.0%
    Check dated 2026-05-04T01:32:07.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page’s displayed software/site revision indicator has been updated from v3.5.0 to v3.5.3. This represents a maintenance/frontend version change rather than an update to the clinical trial information presented.
    Difference
    0.0%
    Check dated 2026-04-26T15:20:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page.